2001/660/EC: Commission Decision of 6 August 2001 updating Decision 2000/112/EC with regard to distribution between antigen banks of antigen reserves (Text with EEA relevance) (notified under document number C(2001) 2472)
Date: 2001-08-06
Institutions: European Commission
Subjects: EU Member State, EU stock, foot-and-mouth disease, geographical distribution, research body, vaccine

30.8.2001

EN

Official Journal of the European Communities

L 232/23

COMMISSION DECISION

of 6 August 2001

updating Decision 2000/112/EC with regard to distribution between antigen banks of antigen
reserves

(notified under document number C(2001) 2472)

(Text with EEA relevance)

(2001/660/EC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European
Community,

Having regard to Council Decision 90/424/EEC of 26 June
1990 on expenditure in the veterinary field (1), as last amended
by Council Decision 2001/12/EC (2), and in particular Article
14 thereof,

Having regard to Council Decision 91/666/EEC of 11
December 1991 establishing Community reserves of foot-and-
mouth disease vaccines (3), as last amended by Commission
Decision 2001/181/EC (4), and in particular Article 7 thereof,

Whereas:

(1)

(2)

(3)

(4)

(5)

In conformity with Decision 91/666/EEC, the purchase
of antigens is a part of the Community action to estab-
lish Community reserves of
foot-and-mouth disease
vaccines.

Annex I to Decision 91/666/EEC details the quantities
and subtypes of antigen of the foot-and-mouth disease
virus to be stored in Community antigen reserves.

By Commission Decision 93/590/EC (5), as last amended
by Decision 2000/112/EC (6), arrangements were made
for purchase of A5, A22 and O1 foot-and-mouth
disease virus antigens.

By Commission Decision 97/348/EC (7), as last amended
by Decision 2000/112/EC, arrangements were made for
the purchase of A22-Iraq, C1 and ASIA1 foot-and-
mouth disease virus antigens.

By Commission Decision 2000/77/EC (8), arrangements
were made for purchase of certain quantities of A Iran
96, A Iran 99, A Malaysia 97, SAT 1, SAT 2 (East
African and Southern African strains) and SAT 3
foot-and-mouth disease virus antigen.

(6)

(7)

By Commission Decision 2000/569/EC (9), arrangements
were made for purchase of additional quantities of
A22-Iraq, O1-Manisa, ASIA 1-Shamir, A Malaysia 97,
SAT 1, SAT 2 (East African and Southern African
strains) and SAT 3 foot-and-mouth disease virus antigen.

Following written information from the contractor
about the supply and distribution to the approved prem-
ises of
the antigen purchased in accordance with
Decision 2000/569/EC, it appears appropriate to update
the Annex to Decision 2000/112/EC detailing the
distribution between antigen banks of antigen reserves
established within the framework of the Community
action concerning reserves of foot-and-mouth disease
vaccines and amending Commission Decisions 93/590/
EC and 97/348/EC.

(8)

The measures provided for in this Decision are in
accordance with the opinion of the Standing Veterinary
Committee,

HAS ADOPTED THIS DECISION:

Article 1

The Annex to Decision 2000/112/EC is replaced by Annex to
this Decision.

This Decision is addressed to the Member States.

Article 2

Done at Brussels, 6 August 2001.

For the Commission

David BYRNE

Member of the Commission

(1) OJ L 224, 18.8.1990, p. 19.
(2) OJ L 3, 6.1.2001, p. 27.
(3) OJ L 368, 31.12.1991, p. 21.
(4) OJ L 66, 8.3.2001, p. 39.
(5) OJ L 280, 13.11.1993, p. 33.
(6) OJ L 33, 8.2.2000, p. 21.
(7) OJ L 148, 6.6.1997, p. 27.
(8) OJ L 30, 4.2.2000, p. 35.

(9) OJ L 238, 22.9.2000, p. 61.

L 232/24

EN

Official Journal of the European Communities

30.8.2001

ANNEX

‘ANNEX

European
Antigen bank

Designated antigen banks

IZP
Brescia

LNPB
Lyon

Antigen type/subtype

Quantity (*)
(× 1 000 000)

Quantity (*)
(× 1 000 000)

Merial S.A.S.
Pirbright/Lyon

Quantity (*)
(× 1 000 000)

European
Antigen bank

Totals
(× 1 000 000)

O1 — Manisa

O1 — BFS

A24 — Cruzeiro

A22 — Iraq

A Iran 96

A Iran 99

A Malaysia 97

C1 — Noville

ASIA1 — Shamir

SAT 1

SAT 2 (E Africa)

SAT 2 (S Africa)

SAT 3

Quantity (*)
(× 1 000 000)
total per site

2,5

2,5

2,5

2,2

2,5

2,5

2,5

2,5

1,5

1,0

2,5

1,5

1,0

1,0

1,5

2,5

2,5

1,5

1,0

1,0

1,0

6,5

3,5

5,0

6,2

1,0

1,0

1,5

5,0

5,0

1,5

1,0

1,0

1,0

10,0

9,7

19,5

39,2

(*) quantity in vaccine equivalent cattle doses.’